What is Biogen's operating income?

Biogen (BIIB) reported operating income of $610.7M in Q1 2022.

What does operating income mean?

Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Biogen BIIB Operating Income

Discontinued — last reported Q1 '22

Operating Income at other companies

Rogers CorporationROG

$10.7M+3,667%

TG TherapeuticsTGTX

$34.8M+304%

Acadia PharmaceuticalsACAD

-$4.62M-124%

AnaptysBio, Inc.ANAB

-$34.64M-25.8%

Syndax PharmaceuticalsSNDX

-$34.2M+59.2%

RegenxbioRGNX

-$83.36M-787%

Other financials

Income statement

See full

Revenue$2.5B+1.9%

Gross profit$1.8B+0.8%

Net income$319.5M+32.8%

EPS (diluted)$2.15+31.1%

Balance sheet

See full

Cash & equivalents$3.4B+30.2%

Total debt$6.6B+34.7%

Total equity$18.7B+9.9%

Total assets$29.5B+5.2%

Cash flow

See full

Operating cash flow$645.5M+149%

CapEx$51.2M+38.0%

Free cash flow$594.3M+167%

Valuation

See full

Market cap$31.9B+71.6%

Enterprise value$35.08B+56.4%

P/E22.5×+10.3×

P/S3.2×+1.4×

Profitability

See full

Gross margin75.5%-0.1pp

Operating margin22.9%—

Net margin14.3%-0.8pp

FCF margin24.4%-0.4pp

Returns & leverage

See full

Return on equity8%-1.2pp

Debt / equity0.4×+0.1×

Current ratio3.1×+1.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Biogen’s 10-Q, filed May 3, 2022, on SEC EDGAR. View the filing →

Ask your AI about Biogen's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biogen's operating income?: Biogen (BIIB) reported operating income of $610.7M in Q1 2022.
What does operating income mean?: Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.